
Over the past few months the majority of the news coming out of the pharmaceutical industry has been a refrain of slashing R&D spending as a result of increasingly competitive drug development.
Jacob Presson is a research analyst at Cutting Edge Information, providing market research to pharmaceutical companies.
Published: October 29th 2013 | Updated: